# First Capital Inc: Form 10-Q for the period ended Jun 30, 2025

- Company: [First Capital Inc](/companies/fcap.md) (CIK 1070296)
- Form: 10-Q
- Filed: 2025-08-14
- Accepted by EDGAR: Aug 14, 2025, 16:32 ET
- Period: 2025-06-30
- Accession: 0001558370-25-011580
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070296/000155837025011580/fcap-20250630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070296/000155837025011580/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-04-01 to 2025-06-30 | $1.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months, 2025-01-01 to 2025-06-30 | $3.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months, 2025-04-01 to 2025-06-30 | $4.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2025-01-01 to 2025-06-30 | $8.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2025-04-01 to 2025-06-30 | $852.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2025-01-01 to 2025-06-30 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-04-01 to 2025-06-30 | $3.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2025-01-01 to 2025-06-30 | $7.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-04-01 to 2025-06-30 | $1.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2025-01-01 to 2025-06-30 | $2.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-04-01 to 2025-06-30 | $1.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2025-01-01 to 2025-06-30 | $2.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-04-01 to 2025-06-30 | 3,350,344,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2025-01-01 to 2025-06-30 | 3,349,308,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2025-01-01 to 2025-06-30 | $8.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2025-01-01 to 2025-06-30 | $489.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2025-01-01 to 2025-06-30 | $2.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2025-01-01 to 2025-06-30 | $9.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2025-06-30 | $1.24bn | us-gaap:Assets |
| Total liabilities | at 2025-06-30 | $1.12bn | us-gaap:Liabilities |
| Short-term borrowings | at 2025-06-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-06-30 | $123.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,134 characters.

| ​ ​ ​ ​ ​ Period ​ | ​ ​ ​ ​ ​ ​ | ​ ​ ​ ​ (a) Total Number of Shares Purchased ​ | ​ ​ ​ ​ ​ ​ | ​ ​ ​ ​ (b) Average Price Paid Per Share ​ | ​ ​ | ​ ​ ​ ​ ​ ​ | ​ (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs ​ | ​ ​ ​ ​ ​ ​ | ​ (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs ​ |
| --- | --- | ---: | --- | --- | --- | --- | ---: | --- | ---: |
| April 1 through April 30, 2025 |  | — |  | ​ | N/A |  | — |  | 113,471 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| May 1 through May 31, 2025 |  | — | ​ | ​ | N/A |  | — |  | 113,471 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| June 1 through June 30, 2025 |  | — | ​ | ​ | N/A |  | — |  | 113,471 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Total |  | — | ​ | ​ | N/A |  | — |  |  |

On August 19, 2008, the board of directors authorized the repurchase of up to 240,467 shares of the Company’s outstanding common stock. The stock repurchase program will expire upon the purchase of the maximum number of shares authorized under the program, unless the board of directors terminates the program earlier.

## Risk factors

As filed, 422 characters.

There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Recent changes in international trade regulation or foreign trade policy, including tariffs, could lead to higher than anticipated inflation and supply chain disruption, which may impact consumer and commercial borrower performance.

Filed Aug 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-011580. Last ingested by Listed: Nov 6, 2026, 18:07 ET. No prices; not investment advice.